Literature DB >> 34921623

Metabolites from Induratia spp. modulating key enzymes in human hemostasis.

Mauro Guilherme Barros Cardoso1, Marcus Vinicius Cardoso Trento2, Pedro Henrique Souza Cesar2, Silvana Marcussi2, Patrícia Gomes Cardoso3.   

Abstract

Induratia spp. fungi have been poorly evaluated for their non-volatile secondary metabolites. In the present work, we evaluated the effects of non-volatile secondary metabolites released into the culture medium by Induratia spp. upon toxic alterations induced by Bothrops spp. venoms. B. atrox venom phospholipase was inhibited by Induratia spp. around 12 and 16%. The extracts of the two strains inhibited 12-25% of the hemolysis induced by B.moojeni venom. Thrombolysis was inhibited by 30-60% by the compounds present in both extracts. The coagulation induced by B. moojeni venom was prolonged by 26-41 s by the action of the extracts of I. coffeana. The fungal extracts did not exert any cytotoxic effect, nor did they induce any alteration in the other evaluated substrates show the potential use of non-volatile metabolites produced by the fungi evaluated as enzyme modulators, especially for proteases with a fundamental role in human hemostasis.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bothrops spp.; Endophytic fungi; Muscodor spp.; Phospholipases; Proteases; Secondary metabolites

Mesh:

Substances:

Year:  2021        PMID: 34921623     DOI: 10.1007/s00203-021-02682-z

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  23 in total

Review 1.  Importance of microbial natural products and the need to revitalize their discovery.

Authors:  Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2013-08-30       Impact factor: 3.346

2.  Are we ready for industrial production of bioactive plant secondary metabolites utilizing endophytes?

Authors:  Souvik Kusari; Michael Spiteller
Journal:  Nat Prod Rep       Date:  2011-06-01       Impact factor: 13.423

3.  Molecular interactions between p-coumaric acid and snake venom toxins.

Authors:  Pedro H S Cesar; Marcus Vinícius Cardoso Trento; Thais A Sales; Tamara R Marques; Mariana A Braga; Teodorico C Ramalho; Silvana Marcussi
Journal:  J Cell Biochem       Date:  2019-04-23       Impact factor: 4.429

4.  Lecanicillium aphanocladii: snake venom phospholipases A2 and proteases as tools to prospect enzymatic inhibitors.

Authors:  M G B Cardoso; M V C Trento; C H Reis; S Marcussi; P G Cardoso
Journal:  Lett Appl Microbiol       Date:  2019-07-01       Impact factor: 2.858

5.  An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica.

Authors:  J M Gutiérrez; C Avila; E Rojas; L Cerdas
Journal:  Toxicon       Date:  1988       Impact factor: 3.033

6.  Batroxase, a new metalloproteinase from B. atrox snake venom with strong fibrinolytic activity.

Authors:  A C O Cintra; L G B De Toni; M A Sartim; J J Franco; R C Caetano; M T Murakami; S V Sampaio
Journal:  Toxicon       Date:  2012-03-30       Impact factor: 3.033

Review 7.  Toxins in thrombosis and haemostasis: potential beyond imagination.

Authors:  R M Kini
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

8.  Enzymatic Modulators from Induratia spp.

Authors:  Andréa Patrícia da Silva Pomposo Bastos; Patrícia Gomes Cardoso; Ítalo Augusto Férrer Melo Santos; Marcus Vinicius Cardoso Trento; Laura Cristina Jardim Porto; Silvana Marcussi
Journal:  Curr Microbiol       Date:  2020-08-31       Impact factor: 2.188

9.  Toxicological Aspects of the Essential Oil from Cinnamodendron dinisii.

Authors:  Milene A Andrade; Maria das Graças Cardoso; Paulo S C Preté; Maurílio J Soares; Camila M O de Azeredo; Marcus V C Trento; Mariana A Braga; Silvana Marcussi
Journal:  Chem Biodivers       Date:  2018-05-06       Impact factor: 2.408

10.  Xanthine oxidase inhibitory and antioxidant potential of Indian Muscodor species.

Authors:  Neha Kapoor; Sanjai Saxena
Journal:  3 Biotech       Date:  2016-11-17       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.